Cargando…

The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity

The aim of the present study was to evaluate the funtion of fenugreek seed mucilage (FSM) as potential matrix forming agent for orodispersible pharmaceutical lyophilisates. The FSM was isolated and characterized. FSM colloidal dispersions were prepared and the rheological evaluation was performed. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Iurian, Sonia, Dinte, Elena, Iuga, Cristina, Bogdan, Cătălina, Spiridon, Iuliana, Barbu-Tudoran, Lucian, Bodoki, Andreea, Tomuţă, Ioan, Leucuţa, Sorin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688226/
https://www.ncbi.nlm.nih.gov/pubmed/29204071
http://dx.doi.org/10.1016/j.jsps.2017.09.006
_version_ 1783279115365777408
author Iurian, Sonia
Dinte, Elena
Iuga, Cristina
Bogdan, Cătălina
Spiridon, Iuliana
Barbu-Tudoran, Lucian
Bodoki, Andreea
Tomuţă, Ioan
Leucuţa, Sorin E.
author_facet Iurian, Sonia
Dinte, Elena
Iuga, Cristina
Bogdan, Cătălina
Spiridon, Iuliana
Barbu-Tudoran, Lucian
Bodoki, Andreea
Tomuţă, Ioan
Leucuţa, Sorin E.
author_sort Iurian, Sonia
collection PubMed
description The aim of the present study was to evaluate the funtion of fenugreek seed mucilage (FSM) as potential matrix forming agent for orodispersible pharmaceutical lyophilisates. The FSM was isolated and characterized. FSM colloidal dispersions were prepared and the rheological evaluation was performed. Oral lyophilisates (OLs) with different FSM concentrations, containing meloxicam as model drug were prepared by freeze drying method. The OLs were characterized and compared to gelatin containing tablets, prepared under the same conditions. The FSM dispersions revealed shear thinning flow type. Based on colloidal dispersions' rheological properties, five FSM concentrations were taken forward to the lyophilization step. Completely dry and elegant tablets were obtained. Texture analysis indicated highly porous structures, confirmed by SEM analysis, which explain the fast disintegration properties. All the prepared tablets disintegrated in less than 47 s. The disintegration process was prolonged by the increase in FSM content, due to the high viscosity the polymer creates in aqueous media. FSM tablets presented longer disintegration times, as compared to gelatin tablets, but also higher crushing strength. Considering the fast disintegration and the high crushing strength, FSM is a good candidate as matrix forming agent for fast disintegrating dosage forms or other freeze-dried preparations.
format Online
Article
Text
id pubmed-5688226
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56882262017-12-04 The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity Iurian, Sonia Dinte, Elena Iuga, Cristina Bogdan, Cătălina Spiridon, Iuliana Barbu-Tudoran, Lucian Bodoki, Andreea Tomuţă, Ioan Leucuţa, Sorin E. Saudi Pharm J Original Article The aim of the present study was to evaluate the funtion of fenugreek seed mucilage (FSM) as potential matrix forming agent for orodispersible pharmaceutical lyophilisates. The FSM was isolated and characterized. FSM colloidal dispersions were prepared and the rheological evaluation was performed. Oral lyophilisates (OLs) with different FSM concentrations, containing meloxicam as model drug were prepared by freeze drying method. The OLs were characterized and compared to gelatin containing tablets, prepared under the same conditions. The FSM dispersions revealed shear thinning flow type. Based on colloidal dispersions' rheological properties, five FSM concentrations were taken forward to the lyophilization step. Completely dry and elegant tablets were obtained. Texture analysis indicated highly porous structures, confirmed by SEM analysis, which explain the fast disintegration properties. All the prepared tablets disintegrated in less than 47 s. The disintegration process was prolonged by the increase in FSM content, due to the high viscosity the polymer creates in aqueous media. FSM tablets presented longer disintegration times, as compared to gelatin tablets, but also higher crushing strength. Considering the fast disintegration and the high crushing strength, FSM is a good candidate as matrix forming agent for fast disintegrating dosage forms or other freeze-dried preparations. Elsevier 2017-12 2017-09-17 /pmc/articles/PMC5688226/ /pubmed/29204071 http://dx.doi.org/10.1016/j.jsps.2017.09.006 Text en © 2017 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Iurian, Sonia
Dinte, Elena
Iuga, Cristina
Bogdan, Cătălina
Spiridon, Iuliana
Barbu-Tudoran, Lucian
Bodoki, Andreea
Tomuţă, Ioan
Leucuţa, Sorin E.
The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity
title The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity
title_full The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity
title_fullStr The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity
title_full_unstemmed The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity
title_short The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity
title_sort pharmaceutical applications of a biopolymer isolated from trigonella foenum-graecum seeds: focus on the freeze-dried matrix forming capacity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688226/
https://www.ncbi.nlm.nih.gov/pubmed/29204071
http://dx.doi.org/10.1016/j.jsps.2017.09.006
work_keys_str_mv AT iuriansonia thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT dinteelena thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT iugacristina thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT bogdancatalina thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT spiridoniuliana thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT barbutudoranlucian thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT bodokiandreea thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT tomutaioan thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT leucutasorine thepharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT iuriansonia pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT dinteelena pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT iugacristina pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT bogdancatalina pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT spiridoniuliana pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT barbutudoranlucian pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT bodokiandreea pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT tomutaioan pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity
AT leucutasorine pharmaceuticalapplicationsofabiopolymerisolatedfromtrigonellafoenumgraecumseedsfocusonthefreezedriedmatrixformingcapacity